PCa growth slowed
London scientists have shown that the drug NXP800, discovered at their institute, slowed the growth of PCa cells, including in cancer cells that are resistant to the hormone therapy enzalutamide (Jan ’25). See here
London scientists have shown that the drug NXP800, discovered at their institute, slowed the growth of PCa cells, including in cancer cells that are resistant to the hormone therapy enzalutamide (Jan ’25). See here